asa guidelines for glp-1 drugs 2025 ADS/ANZCA/GESA/NACOS clinical practice recommendations on the peri-procedural use of GLP-1/GIP receptor agonists How should we approach patients
Description
We invite you to discuss this innovative option with our experienced professionals to explore how it fits into your comprehensive weight loss and aesthetic journey
Clinicians should judiciously balance potential benefits against risks when considering the use of these agents in pregnant patients and, where feasible, engage in thorough preconception counseling.225,226 Future research should prioritize the evaluation of long-term safety outcomes during pregnancy and potential fetal effects to inform safer clinical practices
20% of these adults are obese, or 11m people
SN : Why are you hopeful
Understanding GLP-1 Medications and Coverage Challenges What Are GLP-1 Drugs
Studies were divided between pre-clinical and mechanistic evidence, and clinical evidence
